UK firm set to transform success of IVF treatment
A NEW test being developed by a British company could double the success rates of in vitro fertilisation (IVF) treatment. The breakthrough, one of the most significant developments in the $10bn (E7.7bn, $5.1bn) market for IVF in years, could transform the lives of couples struggling to conceive.
The technology should reduce the average cost of treatment and increase availability at a time when private clinics are under attack for overcharging and raising expectations of their chances of success.
The new technique, known as “comparative genomic hybridisation�?, involves taking a small sample of DNA from the outside membrane of the egg before it has been fertilised and screening its chromosomes. more…
.